D
Celldex Therapeutics, Inc. CLDX
$21.75 -$0.18-0.82% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -32.88% -23.45% -11.62% -23.65% -32.78%
Total Depreciation and Amortization 7.97% 6.93% 5.62% 6.67% 9.62%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 51.64% 17.23% 4.76% 3.00% 10.87%
Change in Net Operating Assets -295.06% -542.31% -260.46% -380.79% 146.03%
Cash from Operations -53.25% -43.69% -47.06% -63.53% -7.78%
Capital Expenditure -59.20% -16.68% -5.56% -31.87% 8.51%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 132.10% 114.80% -177.22% -593.48% -574.81%
Cash from Investing 131.57% 114.37% -174.27% -602.46% -582.76%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -99.71% -99.15% 102.07% 26,460.59% 14,419.77%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -99.71% -99.15% 102.07% 26,460.59% 14,419.77%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -235.69% -260.68% -219.93% 498.39% 8,300.56%